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Characterisation
Tool, genomics, personalized medicine, meta-data, data,
annotation, integration, visualization, open source/free.
Description
MOLGENIS/omx [1] is a generic toolbox for multi-omics
and personalized medicine studies such as EU-Panacea,
EU-BioSHaRE, EU-BioMedBridges, NL-String of Pearls,
and CTMM/Triumph. OMX comes with a simple Excel
format to upload data; a powerful data explorer to find
and filter data; a genome browser; an R statistical pro-
gramming interface for bioinformaticians and integrated
annotation tools for Chembl, Ensembl, OMIM, etc.
Increasingly bigger datasets are required for epidemiolo-
gical and genetic analysis and hence, it has ‘big data’
stores connected using VCF and Elastic searches. MOL-
GENIS/omx gave rise to a variety of web applications in
the life science domain, including omics data warehouses,
patient mutation registries, and clinical data integration
platforms. For example, the WormQTLHD database [2]
* Correspondence: m.a.swertz@rug.nl
Genomics Coordination Center, Department of Genetics, University Medical
Center Groningen, 9700 RB Groningen, the Netherlands
Figure 1 MOLGENIS/omx genome browser in the COL7A mutation database.




© 2015 Swertz and van der Velde; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
contains over 60 omics data sets contributed by the inter-
national C. elegans research community. Patient registries
such as those developed for MVID [3], Dystrophic EB,
and CHARGE syndrome enable clinicians to enter data
about patient phenotypes and causal mutations. MOL-
GENIS/omx most recent application is to facilitate inter-
pretation of the massive amounts of genomics data,
including eQTL pathogenicity predictions, and/or clinical
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